Literature DB >> 12013550

A pharmacokinetic model for estimating exposure of Americans to dioxin-like compounds in the past, present, and future.

Matthew Lorber1.   

Abstract

Empirical evidence suggests that exposure of Americans to dioxin-like compounds was low during the early decades of the 20th century, then increased during the 1940s and 1950s, reaching a peak in the 1960s and 1970s, and progressively decreased to lower levels in the 1980s and 1990s. Such evidence includes dioxin analysis of carbon-dated sediment cores of lakes and rivers, preserved meat samples from different decades of the 20th century, and limited body burden measurements of dioxin-like compounds. Pinsky and Lorber (1998) summarized studies measuring 2,3,7,8-TCDD in blood and adipose tissue, and found a range of 10-20 pg/g (ppt) lipid during the 1970s, and 2-10 ppt lipid during the 1980s. This study reviews body burdens of dioxin toxic equivalents, TEQs, to find a range from approximately 50 to 80 ppt lipid during the 1970s, 30-50 ppt lipid during the 1980s, and 10-20 ppt lipid during the 1990s (TEQs comprised of the 17 dioxin and furan congeners only). Pinsky and Lorber (1998) investigated historical exposure trends for 2,3,7,8-TCDD by using a single-compartment, first-order pharmacokinetic model. The current study extends this prior effort by modeling dioxin TEQs instead of the single compound, 2,3,7,8-TCDD. TEQs are modeled as though they were a single compound, in contrast to an approach where the individual dioxin and furan congeners are modeled separately. It was found that body burdens of TEQs during the 1970s, 1980s and 1990s could be modeled by assuming a historical dose which began the century at low levels of approximately 0.5 pg TEQ/kg/day, rose during the middle decades of the 20th century to over 6 pg TEQ/kg/day, and declined to current levels of approximately 0.5 pg TEQ/kg/day. Trends in individual and population body burdens of TEQs are also investigated using this PK modeling framework. A key uncertainty of this effort - assuming that TEQs behave as though they were a single compound - is discussed and analyzed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12013550     DOI: 10.1016/s0048-9697(01)01119-6

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  11 in total

1.  Application of pharmacokinetic modelling for 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure assessment.

Authors:  P Ruiz; L L Aylward; M Mumtaz
Journal:  SAR QSAR Environ Res       Date:  2014-11-14       Impact factor: 3.000

2.  Plasma levels of dioxins, furans, non-ortho-PCBs, and TEQs in the Seveso population 17 years after the accident.

Authors:  D Consonni; Raffaella Sindaco; L Agnello; N E Caporaso; Maria Teresa Landi; Angela Cecilia Pesatori; P A Bertazzi
Journal:  Med Lav       Date:  2012 Jul-Aug       Impact factor: 1.275

3.  Physiologically based pharmacokinetic toolkit to evaluate environmental exposures: Applications of the dioxin model to study real life exposures.

Authors:  Claude Emond; Patricia Ruiz; Moiz Mumtaz
Journal:  Toxicol Appl Pharmacol       Date:  2016-12-10       Impact factor: 4.219

4.  Assessment of nonoccupational exposure to DDT in the tropics and the north: relevance of uptake via inhalation from indoor residual spraying.

Authors:  Roland Ritter; Martin Scheringer; Matthew MacLeod; Konrad Hungerbühler
Journal:  Environ Health Perspect       Date:  2011-05       Impact factor: 9.031

5.  Temporal trends in serum concentrations of polychlorinated dioxins, furans, and PCBs among adult women living in Chapaevsk, Russia: a longitudinal study from 2000 to 2009.

Authors:  Olivier Humblet; Oleg Sergeyev; Larisa Altshul; Susan A Korrick; Paige L Williams; Claude Emond; Linda S Birnbaum; Jane S Burns; Mary M Lee; Boris Revich; Andrey Shelepchikov; Denis Feshin; Russ Hauser
Journal:  Environ Health       Date:  2011-06-22       Impact factor: 5.984

6.  Thyroid-hormone-disrupting chemicals: evidence for dose-dependent additivity or synergism.

Authors:  Kevin M Crofton; Elena S Craft; Joan M Hedge; Chris Gennings; Jane E Simmons; Richard A Carchman; W Hans Carter; Michael J DeVito
Journal:  Environ Health Perspect       Date:  2005-11       Impact factor: 9.031

7.  A multi-individual pharmacokinetic model framework for interpreting time trends of persistent chemicals in human populations: application to a postban situation.

Authors:  Roland Ritter; Martin Scheringer; Matthew MacLeod; Urs Schenker; Konrad Hungerbühler
Journal:  Environ Health Perspect       Date:  2009-05-01       Impact factor: 9.031

8.  A margin-of-exposure approach to assessment of noncancer risks of dioxins based on human exposure and response data.

Authors:  Lesa L Aylward; Julie E Goodman; Gail Charnley; Lorenz R Rhomberg
Journal:  Environ Health Perspect       Date:  2008-06-16       Impact factor: 9.031

9.  The University of Michigan Dioxin Exposure Study: methods for an environmental exposure study of polychlorinated dioxins, furans, and biphenyls.

Authors:  David H Garabrant; Alfred Franzblau; James Lepkowski; Brenda W Gillespie; Peter Adriaens; Avery Demond; Barbara Ward; Kathy Ladronka; Elizabeth Hedgeman; Kristine Knutson; Lynn Zwica; Kristen Olson; Timothy Towey; Qixuan Chen; Biling Hong
Journal:  Environ Health Perspect       Date:  2008-12-22       Impact factor: 9.031

10.  The University of Michigan Dioxin Exposure Study: predictors of human serum dioxin concentrations in Midland and Saginaw, Michigan.

Authors:  David H Garabrant; Alfred Franzblau; James Lepkowski; Brenda W Gillespie; Peter Adriaens; Avery Demond; Elizabeth Hedgeman; Kristine Knutson; Lynn Zwica; Kristen Olson; Timothy Towey; Qixuan Chen; Biling Hong; Chiung-Wen Chang; Shih-Yuan Lee; Barbara Ward; Kathy Ladronka; William Luksemburg; Martha Maier
Journal:  Environ Health Perspect       Date:  2008-12-22       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.